| association id |
FEATURE |
Drug id |
Propr |
Public |
Drug Name |
Drug Target |
N FEATURE pos |
N FEATURE neg |
log max Conc tested |
FEATURE neg logIC50 MEAN |
FEATURE pos logIC50 MEAN |
FEATURE deltaMEAN IC50 |
FEATURE IC50 effectSize |
FEATURE neg Glass delta |
FEATURE pos Glass delta |
ANOVA FEATURE pval |
Tissue ANOVA pval |
MSI ANOVA pval |
ANOVA FEATURE FDR % |
a248 |
HGF_mut |
1024 |
1 |
1 |
CEP-701 |
FLT3, JAK2, NTRK1, RET |
4 |
842 |
0.693 |
-0.637 |
2.43 |
3.06 |
2 ** |
2 ** |
2.1 ** |
1.54e-04 |
4.81e-28 |
9.05e-02 |
10 |
a269 |
HGF_mut |
268 |
1 |
1 |
YM155 |
BIRC5 (Survivin) |
5 |
883 |
1.63 |
-3.72 |
0.603 |
4.32 |
1.8 * |
1.8 * |
1.2 * |
1.8e-04 |
1.99e-09 |
3.96e-01 |
11 |
a285 |
HGF_mut |
1015 |
1 |
1 |
CI-1040 |
MAP2K1 (MEK1), MAP2K2 (MEK2) |
4 |
832 |
2.3 |
2.23 |
4.29 |
2.06 |
1.4 * |
1.4 * |
1.8 * |
2.08e-04 |
3.61e-38 |
2.67e-02 |
12 |
a295 |
HGF_mut |
1022 |
1 |
1 |
AZD7762 |
CHEK1, CHEK2 |
4 |
842 |
0.693 |
-0.478 |
2.54 |
3.01 |
2 ** |
2 ** |
10 ** |
2.26e-04 |
1.13e-32 |
4.37e-01 |
13 |
a510 |
HGF_mut |
182 |
1 |
1 |
Obatoclax Mesylate |
BCL2, BCL2L1, MCL1 |
5 |
859 |
2.77 |
-0.918 |
1.68 |
2.59 |
1.5 * |
1.5 * |
0.92 . |
7.55e-04 |
5.32e-14 |
2.97e-02 |
24 |
